SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Jun-24 8:38 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 17-Jun-24 | Sale (Planned) | 7,266 | $12.33 | $89,589.80 | (18%) 39.61K to 32.34K | |
14-Feb-24 8:21 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Grant | 3,320 | -- | -- | 9% 37.26K to 40.58K | |
14-Feb-24 8:21 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Payment of Exercise | 973 | $12.41 | $12,074.90 | (2%) 40.58K to 39.61K | |
06-Dec-23 8:29 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Dec-23 | Sale | 2,125 | $9.63 | $20,463.80 | (5%) 39.38K to 37.26K | |
05-Dec-23 9:21 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-23 | Payment of Exercise | 753 | $9.49 | $7,145.97 | (2%) 40.14K to 39.38K | |
15-Feb-23 9:51 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Grant | 20,997 | -- | -- | 81% 25.87K to 46.86K | |
15-Feb-23 9:51 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Payment of Exercise | 6,725 | $52.77 | $354,878.00 | (14%) 46.86K to 40.14K | |
05-Dec-22 7:27 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-22 | Payment of Exercise | 498 | $44.33 | $22,076.30 | (2%) 26.36K to 25.87K | |
28-Nov-22 6:38 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 23-Nov-22 | Grant | 18,500 | -- | -- | 235% 7.86K to 26.36K | |
15-Feb-22 9:51 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Grant | 1,616 | -- | -- | 24% 6.8K to 8.42K | |
15-Feb-22 9:51 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Payment of Exercise | 552 | $62.49 | $34,494.50 | (7%) 8.42K to 7.86K | |
23-Nov-21 8:00 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-Nov-21 | Grant | 6,800 | -- | -- | 100% 0 to 6.8K |